Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study.
Qian GengHua ShenWenyu ZhuYingzhi LuMengjie WangHua JiangDongqing LiPublished in: OncoTargets and therapy (2020)
Low-dose apatinib monotherapy might be an option for patients with advanced lung squamous-cell carcinoma.